From the Forest. Not a Factory.

The Jarrah Activation Protocol

What peer-reviewed research tells us about Australian Jarrah honey in topical application – and why precision matters

This post presents the peer-reviewed scientific basis for the Jarrah Activation Protocol – the MIC data, activation mechanism, biofilm rationale, and evidence for each ingredient. The formulation method, ingredient quantities, and step-by-step instructions are in the original protocol post. If you’re here for the science, read on.

There is a published study, peer-reviewed, conducted by researchers at the University of Sydney and the University of Technology Sydney, that tested Australian Jarrah honey specifically against the fungi responsible for tinea pedis.

The minimum concentrations required to kill Trichophyton rubrum – the organism responsible for the majority of athlete’s foot infections globally – ranged from 4 – 5% (w/v) Jarrah honey.

The protocol below uses substantially more than that.

This post sets out the scientific basis for every element of the formulation: why each ingredient was selected, what the water actually does, why fresh mixing is not optional, and what peer-reviewed microscopy has documented happening to fungal cells when Jarrah honey is applied correctly.

The Organisms and the Problem

Dermatophytes are filamentous fungi that infect the hair, skin, and nails. The infections they cause – collectively called tineas – are among the most prevalent fungal conditions in the world. Tinea pedis (athlete’s foot) affects an estimated 20 – 25% of adults. Onychomycosis, tinea of the nails, has risen from 2% to 14% incidence in developed countries over recent decades. It has been estimated that almost everyone will acquire a dermatophyte infection at some point in their lifetime.¹

Current topical antifungal treatments require daily or twice-daily application for weeks to months, and relapse is common. The treatment limitations have generated sustained scientific interest in natural alternatives – including honey.²

The Jarrah Honey Research

In 2021, researchers from the University of Sydney, the University of Technology Sydney, and RMIT University published a study in Pathogens (MDPI) characterising the antifungal activity of Australian Jarrah honey (Eucalyptus marginata) against six dermatophyte species.³ The paper is the most specific piece of published research on Jarrah honey and the organisms that cause tinea. Its findings are direct and applicable to this protocol.

The MIC results

Jarrah honey inhibited all six dermatophyte species tested, with minimum inhibitory concentrations (MICs) ranging from 1.5–3.5% (w/v) and minimum fungicidal concentrations from 2–5% (w/v). The two organisms most commonly associated with athlete’s foot – Trichophyton rubrum and Trichophyton interdigitale – were inhibited at 2.5–3.5% and killed at 4–5%.

These concentrations are the lowest reported for any honey type against these organisms. For context: the concentration of Jarrah honey in a single application of this protocol substantially exceeds those thresholds.

The susceptibility comparison

The study found that dermatophytes are approximately ten times more susceptible to Jarrah honey than Candida species in comparable testing. The authors attribute this to the particular vulnerability of filamentous fungi to hydrogen peroxide-based activity.³

What was observed under the microscope

Scanning electron microscopy of T. rubrum hyphae following honey treatment documented visible structural consequences. At 1× MIC: prominent ballooning and protrusion of the hyphal surface. At 2× MIC: shrunken, collapsed hyphae with roughened, damaged surface architecture. The microscopy images are published in full in the paper and represent some of the most direct visual documentation of honey’s antifungal action on dermatophyte hyphae available in the literature.

The germination finding

Jarrah honey at half the minimum inhibitory concentration completely suppressed the germination of T. rubrum conidia – the spore-stage from which new infections establish. This is significant for the continuation protocol. Dormant conidia that survive primary treatment are the primary mechanism of recurrence.

The synergy finding

When researchers neutralised hydrogen peroxide using catalase, MICs increased substantially – confirming H₂O₂ as the primary mechanism. However, artificial honey spiked with equivalent H₂O₂ concentrations was unable to replicate Jarrah honey’s full antifungal effect. This indicates that Jarrah contains additional synergising compounds beyond peroxide alone. The researchers identify polyphenols, antimicrobial peptides, Maillard reaction products, and gluconic acid as candidates.³ The identity of these synergists has not yet been fully characterised, which is an honest and important scientific position – and one that distinguishes a genuinely complex bioactive system from a simple antiseptic.

The paper’s conclusion

The authors state directly that given the hyper-susceptibility of dermatophytes to Jarrah honey and the topical, superficial nature of these infections, tineas could be effectively treated using ointments or gels incorporating active Jarrah honey.³

This protocol is precisely that.

What Total Activity Measures – and What TA35+ Means

The TA rating on a jar of Jarrah honey is widely understood as a measure of antibacterial potency. This is accurate but incomplete.

Total Activity is measured by the phenol equivalence assay – the same methodology used by ALS New Zealand to certify our Jarrah TA35+. The assay measures the antimicrobial potency of a 25% honey solution against microbial growth using Staphylococcus aureus ATCC 25923 as the test organism, with results expressed as the equivalent concentration of phenol producing the same inhibitory zone.⁴ The methodology captures both antibacterial and antifungal activity – TA is not an antibacterial-specific measure.

Cokcetin et al. (2016), in the most comprehensive peer-reviewed study of Australian Leptospermum honey antibacterial activity to date, confirmed that Non-Peroxide Activity (NPA) – measured by precisely this phenol equivalence assay – is equivalent to the Unique Manuka Factor (UMF), the grading system used for New Zealand Leptospermum honey.⁵ The same study demonstrated a strong positive correlation (r² = 0.95) between methylglyoxal (MGO) content and NPA across 80 Australian Leptospermum honey samples. TA is the broader measure: where NPA captures only the non-peroxide component (assessed after catalase treatment to remove hydrogen peroxide), TA captures total antimicrobial activity – peroxide and non-peroxide – making it the more complete potency measure for a predominantly H₂O₂-active honey like Jarrah.

Our Jarrah TA35+, batch CL515012435, tested April 2025, was confirmed at phenol equivalence 53.8 by ALS New Zealand (IANZ-accredited, ISO/IEC 17025). The Independent Testing Summary for this batch is available at the Transparency Hub.

One caveat the 2021 paper makes explicit, and which this post repeats: H₂O₂-producing honeys can be highly variable in activity depending on age, processing, and storage conditions. The authors note that correctly stored, highly active Jarrah samples can retain therapeutically useful activity for many years – but batch verification matters. The TA rating and batch number on your jar are not marketing. They are the activity confirmation.

The Activation Mechanism – Why the Water is NOT a Dilutent

This is the most widely misunderstood aspect of honey’s antimicrobial action, and the most important to understand for topical use.

Raw honey in its concentrated form is largely inert as an antimicrobial. The enzyme responsible for its primary mechanism – glucose oxidase – is inhibited in honey’s low-water, high-viscosity state. When honey is diluted with water, glucose oxidase activates. It acts on glucose to produce hydrogen peroxide (H₂O₂), a potent oxidising agent.

Research by Bang et al. (2003) demonstrated that the maximum level of H₂O₂ production – potentially ranging from 5 to 100 μg H₂O₂ per gram of honey – is achieved at a 30–50% honey dilution.⁶ H₂O₂ levels of between 1 and 2.5 mM have been demonstrated sufficient to kill E. coli in as little as 15 minutes.⁷

This activation chemistry is the reason the protocol instructs you to add freshly boiled and cooled water to the honey at the point of application – not as a vehicle or a moisturiser, but as the trigger for antimicrobial activity. Undiluted honey applied to dry skin activates slowly and incompletely. Honey in a water-emulsion applied to skin activates quickly and fully.

Freshly boiled water is specified because water quality and temperature affect enzymatic activity. Residual heat above the enzyme’s tolerance threshold would compromise H₂O₂ generation. This is why the instruction specifies boiled and cooled – not warm, not tap.

The Biofilm Dimension – Why You Continue After Symptoms Resolve

A 2019 study in Scientific Reports (Nature Publishing Group), conducted by researchers at the University of Technology Sydney and the University of Sydney, investigated honey’s capacity to prevent and eradicate biofilms formed by Pseudomonas aeruginosa – a particularly treatment-resistant wound pathogen and common chronic wound coloniser.⁸

The study demonstrated that manuka-type honeys at clinically obtainable concentrations (64–80%) completely eradicated established P. aeruginosa biofilms. Of equal relevance here: the paper confirmed that bacteria embedded within biofilm matrices are substantially more tolerant of antimicrobial agents than their planktonic (free-floating) counterparts – a finding consistent across both bacterial and fungal biofilm literature.

In chronic and nail dermatophyte infections, fungi can adopt biofilm-like structural arrangements within the nail plate and deeper stratum corneum layers. This architecture is the primary reason short-duration topical treatments frequently fail to achieve durable clearance. The fungi are not resistant to the antifungal agent. They are structurally protected from it.

The study also confirmed that bacteria do not develop resistance to honey under experimental conditions that rapidly induce resistance to conventional antibiotics. This low propensity for resistance reflects the multi-mechanism complexity of honey’s antimicrobial action – it acts simultaneously through H₂O₂, osmotic pressure, low pH, antimicrobial peptides, and polyphenols, making single-pathway resistance essentially impossible.⁸

The protocol instruction to continue for 1–2 weeks after visible symptoms resolve is not conservative caution. It is the biofilm clearance window. Surface-level colony disruption occurs before deeper structural resolution. Stopping at symptom clearance is the most common reason for recurrence.

The Anti-Inflammatory Mechanisms

Dermatophyte infections produce localised inflammatory responses – redness, swelling, itching – as the immune system responds to fungal invasion. Honey’s anti-inflammatory activity operates through documented mechanisms that are relevant to the resolution of these symptoms.

Published research identifies the following anti-inflammatory pathways in bioactive honey: inhibition of matrix metallopeptidase 9 (MMP-9); suppression of reactive oxygen species through inhibition of macrophages, monocytes, neutrophils, keratinocytes, and leukocytes; and inhibition of inflammatory pathway markers including IL-1, IL-6, IL-10, COX-2, TNF-α, NF-κB, and prostaglandins.⁹

The antioxidant contribution is separately relevant. Jarrah TA35+ registers antioxidant activity of 473 mg AAE/kg by DPPH radical scavenging assay.¹⁰ The antioxidant mechanism operates through free radical scavenging, hydrogen donation, metallic ion chelation, and elevation of endogenous antioxidant compounds including beta-carotene, vitamin C, and glutathione reductase. Applied to inflamed skin, this suppresses oxidative stress at the site while the antimicrobial system addresses the underlying cause.

The Wound Healing Literature 

A systematic review by Vandamme et al. (2013), published in Burns, confirmed beneficial effects of honey across all three stages of wound healing: haemostasis, inflammation, and remodelling.¹¹ Documented mechanisms include reduction of oedema and wound exudate, promotion of collagen synthesis, stimulation of fibroblast and epithelial cell growth, and prevention of scar tissue and keloid formation.

A narrative review and meta-analysis by Oryan et al. (2016), published in the Journal of Tissue Viability, confirmed that honey’s antimicrobial and antioxidant activities contribute directly to its wound remediation effects.¹²

These findings apply most directly to skin that has been compromised or broken by infection. The biomimetic lipid base in this protocol supports the skin’s barrier repair alongside the honey’s bioactive work – a formulation decision the wound healing literature supports.

The Botanical Context 

The antifungal activity of Jarrah honey is not generic. It is a product of botanical origin.

Jarrah (Eucalyptus marginata) belongs to the Myrtaceae family, subfamily Myrtoideae – the same subfamily as the Leptospermum species from which Manuka honey is derived. The two are botanical relatives at the subfamily level: different genus, different expression of bioactivity, but sharing the same underlying plant lineage that accounts for the bioactive properties of both.¹³

Jarrah’s activity is primarily hydrogen peroxide-based, rather than the methylglyoxal (MGO)-based activity of Manuka. This distinction matters for topical use: H₂O₂-based activity is activated upon dilution, making it dynamic and responsive. MGO-based activity is stable in the honey itself. Neither is superior in all contexts. For activated topical application with water as the trigger, a high-activity H₂O₂-producing honey – Jarrah specifically – is the scientifically indicated choice.

The 2021 paper by Guttentag et al. found that dermatophytes were more susceptible to H₂O₂-producing honeys (including Jarrah) than to Leptospermum (Manuka) honey. The MICs for Jarrah were 2–7 times lower than for the Leptospermum sample tested.³

The Ingredient Philosophy

Each ingredient in this formulation was selected on two criteria: documented function and verified provenance.

Raw beeswax with natural propolis

The structural component and propolis extraction vehicle. Propolis – the resinous substance bees collect from plant sources – is present naturally in unfiltered beeswax. Research by de Castro et al. (2011) documented propolis-induced cell death in fungal cells, with increased oxidative stress observed in treated yeast cells within minutes of exposure.¹⁴ The 45–60 minute extraction phase at 65–70°C in this protocol is the step that draws propolis actives into the oil phase. This step cannot be shortened without reducing extraction yield.

Jojoba oil (cold-pressed, 100% Australian)

Technically a liquid wax ester rather than an oil, jojoba is structurally identical to human sebum. This makes it a biomimetic carrier – it opens the skin’s surface for absorption rather than sitting on top of it. Australian sourcing is specified because imported blends can include solvent-extracted fractions that alter the lipid profile.

Macadamia oil (cold-pressed, food-grade, Australian)

The repair lipid. Its unusually high palmitoleic acid content (16:1 fatty acid) mirrors the composition of healthy stratum corneum. Cold-pressed and food-grade because the skin’s standard should match the table’s.

Lanolin (anhydrous, cosmetic/medical grade, low pesticide residue)

Wool fat. One of the oldest and most effective barrier repair agents documented in dermatological literature. Anhydrous specification ensures no water is introduced into the lipid phase, which would compromise stability and provide a medium for microbial growth.

Vitamin E (mixed tocopherols, natural – not synthetic dl-alpha)

Added at cool-down to preserve activity. Mixed tocopherols provide the full natural antioxidant spectrum. Synthetic dl-alpha tocopherol is a single isolated form with lower biological activity than the natural mixed fraction.

Tea tree essential oil (1–2 drops, Part B only).

Melaleuca alternifolia. Terpinen-4-ol, the primary active compound in tea tree oil, has independently documented antifungal activity against dermatophyte species and acts through membrane disruption. One to two drops is the functional dose. More is not more — tea tree at higher concentrations is a sensitiser.

The Protocol

Part A – Repair Balm

*100 g batch. Make once, store in a clean glass jar.*

IngredientQuantityFunction
Raw beeswax with natural propolis18 gStructure + propolis extraction
Jojoba oil, cold-pressed34 gSebum-identical carrier
Macadamia oil, cold-pressed26 gStratum corneum lipid repair
Lanolin, anhydrous20 gBarrier reconstruction
Vitamin E, mixed tocopherols1 gAntioxidant system preservation

Method

Step 1 — Propolis extraction.

Combine beeswax, jojoba oil, and macadamia oil in a double boiler. Heat to 65–70°C. Hold for 45–60 minutes, stirring occasionally. This hold time extracts propolis actives into the oil phase. Shortening it reduces extraction yield. Do not exceed 70°C.

Step 2 — Add lanolin. 

In the final 10–15 minutes, add lanolin. Continue heating until fully melted and the mixture is uniform.

Step 3 — Cool.

Remove from heat. Allow to cool to below 45°C before adding vitamin E. Above this temperature, tocopherol activity degrades.

Step 4 — Add vitamin E.

Stir thoroughly.

Step 5 — Pour and set.

Pour into clean glass jars. Set at room temperature. Do not refrigerate during setting.

Use Part A alone for daily barrier maintenance on lips, dry skin, and compromised areas.

Part B – Active Application

Mixed fresh at point of use. Never stored after mixing.

IngredientPer applicationFunction
Part A balm½ teaspoonLipid delivery matrix
Jarrah TA35+ honey½ teaspoonAntimicrobial + antifungal active
Freshly boiled and cooled water½ teaspoonGlucose oxidase activation trigger
Tea tree essential oil1 drop (max 2)Terpinen-4-ol antifungal activity

Method 

Combine balm, honey, and water in a clean spoon or small ceramic dish. Mix for 20–30 seconds until a loose emulsion forms. Add tea tree. Mix briefly. Apply immediately.

Do not store after mixing. The water-phase activation begins at the point of mixing. A pre-mixed and stored preparation would degrade the honey’s enzymatic activity over time and require a preservative to prevent microbial growth in the water phase.

Application Protocol

Wash the affected area. Dry completely – particularly between digits. Moisture beneath the application creates conditions that favour fungal persistence.

Apply a thin layer only. The formula is concentrated. Over-application provides no additional benefit and creates unnecessary occlusion.

Leave on. Do not rinse.

Frequency:

Twice daily, minimum.

Duration:

Continue for 1–2 weeks after visible symptoms resolve. Dormant conidia and biofilm-embedded cells persist after surface symptoms clear. This is the evidence basis for the continuation window — not excess caution.

Contraindications and Patch Testing

Conduct a patch test before first use. Tea tree oil, propolis, and lanolin each carry sensitisation potential in a proportion of individuals. Apply a small amount to the inner arm. Wait 24 hours before proceeding to full application.

Do not apply to wet or actively weeping skin.

Do not apply to open wounds or broken skin without professional guidance.

The Honey Used in this Protocol

The Jarrah TA35+ specified in this protocol is batch CL515012435, tested April 2025. Total Activity confirmed at 53.8 phenol equivalence by ALS New Zealand (IANZ-accredited, ISO/IEC 17025). Five ISO/IEC 17025 accredited laboratories involved in testing, including Holistic International (UAE-based).

Activity is confirmed to batch, not assumed from varietal. The 2021 Guttentag et al. paper noted explicitly that Jarrah honey activity can vary significantly between samples, and that a commercial Jarrah honey in one study showed no activity against T. rubrum while others showed potent activity. High TA confirmed by accredited laboratory testing is the differentiating criterion.

The Independent Testing Summary for batch CL515012435 is available to download at the Transparency Hub. The original lab reports are available on request via info@australianwildflower.au.

References

  1. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. *Mycoses* 2008; 51:2–15. doi: 10.1111/j.1439-0507.2008.01606.x.
  2. Gupta AK, Chow M, Daniel CR, Aly R. Treatments of tinea pedis. *Dermatol Clin* 2003; 21:431–462.
  3. Guttentag A, Krishnakumar K, Cokcetin N, Hainsworth S, Harry E, Carter D. Inhibition of Dermatophyte Fungi by Australian Jarrah Honey. *Pathogens* 2021; 10(2):194. doi: 10.3390/pathogens10020194.
  4. Hossain ML, Lim LY, Hammer K, Hettiarachchi D, Locher C. A Review of Commonly Used Methodologies for Assessing the Antibacterial Activity of Honey and Honey Products. *Antibiotics (Basel)* 2022; 11(7):975. doi: 10.3390/antibiotics11070975.
  5. Cokcetin NN, Pappalardo M, Campbell LT, Brooks P, Carter DA, Blair SE, Harry EJ. The Antibacterial Activity of Australian Leptospermum Honey Correlates with Methylglyoxal Levels. *PLoS ONE* 2016; 11(12):e0167780. doi: 10.1371/journal.pone.0167780.
  6. Bang LM, Buntting C, Molan P. The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. *J Altern Complement Med* 2003; 9:267–273. doi: 10.1089/107555303623383.
  7. Imlay JA, Linn S. Bimodal pattern of killing of DNA repair-defective or anoxically grown *Escherichia coli* by hydrogen peroxide. *J Bacteriol* 1986; 166:519–527.
  8. Lu J, Cokcetin NN, Burke CM, Turnbull L, Liu M, Carter DA, Whitchurch CB, Harry EJ. Honey can inhibit and eliminate biofilms produced by *Pseudomonas aeruginosa*. *Scientific Reports* 2019; 9:18160. doi: 10.1038/s41598-019-54576-2.
  9. Australian Wildflower Overview of Scientific Research into Raw Honey — Mechanisms of Anti-Inflammatory Effects of Raw Honey, citing: Cianciosi D et al. *Molecules* 2018; 23:2322.
  10. Y-Trace. Certificate of Analysis — Analysis of Antioxidant Activity Using the DPPH Radical Scavenging Assay. Batch CL515012435. Tested April 2025.
  11. Vandamme L, Heyneman A, Hoeksema H, Verbelen J, Monstrey S. Honey in modern wound care: A systematic review. *Burns* 2013; 39:1514–1525. doi: 10.1016/j.burns.2013.06.014.
  12. Oryan A, Alemzadeh E, Moshiri A. Biological properties and therapeutic activities of honey in wound healing. *J Tissue Viability* 2016; 25:98–118. doi: 10.1016/j.jtv.2015.12.002.
  13. Australian Wildflower Overview of Scientific Research into Raw Honey — Botanical Origin Determines Honey Bioactivity.
  14. de Castro PA, Savoldi M, Bonatto D, Barros MH, Goldman MH, Berretta AA, Goldman GH. Molecular characterization of propolis-induced cell death in *Saccharomyces cerevisiae*. *Eukaryot Cell* 2011; 10:398–411. doi: 10.1128/EC.00256-10.

*This post presents published peer-reviewed scientific research for informational and educational purposes. It does not constitute medical advice, a diagnosis, or a recommended treatment for any condition. If you are experiencing a persistent or worsening skin condition, consult a qualified healthcare professional. Conduct a patch test before first use of any topical formulation. Individual responses to natural ingredients including tea tree oil, propolis, and lanolin vary.* 

The Editorial Team produces educational content on honey - provenance, independent testing, and how honey's measured properties are actually established. The team works from primary sources: Scientific research, peer-reviewed literature, laboratory results and information from subject matter experts such as scientists, beekeepers and honey sommeliers. Scientific content is reviewed for accuracy before publication. The team holds to journalistic - state only what the evidence supports, name the source, and correct the record when the data does.

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment

Name

Home Shop Cart 0 Wishlist Account
Shopping Cart (0)

No products in the cart. No products in the cart.